Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 584

1.

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.

Giannini SL, Hanon E, Moris P, Van Mechelen M, Morel S, Dessy F, Fourneau MA, Colau B, Suzich J, Losonksy G, Martin MT, Dubin G, Wettendorff MA.

Vaccine. 2006 Aug 14;24(33-34):5937-49. Epub 2006 Jun 19.

PMID:
16828940
[PubMed - indexed for MEDLINE]
2.

A human papillomavirus type 16 vaccine by oral delivery of L1 protein.

Sasagawa T, Tani M, Basha W, Rose RC, Tohda H, Giga-Hama Y, Azar KK, Yasuda H, Sakai A, Inoue M.

Virus Res. 2005 Jun;110(1-2):81-90.

PMID:
15845258
[PubMed - indexed for MEDLINE]
3.

AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.

Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H, Kielland A, Vosters O, Vanderheyde N, Schiavetti F, Larocque D, Van Mechelen M, Garçon N.

J Immunol. 2009 Nov 15;183(10):6186-97. doi: 10.4049/jimmunol.0901474. Epub 2009 Oct 28.

PMID:
19864596
[PubMed - indexed for MEDLINE]
Free Article
4.

Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach.

Garçon N, Morel S, Didierlaurent A, Descamps D, Wettendorff M, Van Mechelen M.

BioDrugs. 2011 Aug 1;25(4):217-26. doi: 10.2165/11591760-000000000-00000. Review.

PMID:
21815697
[PubMed - indexed for MEDLINE]
5.

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.

Harro CD, Pang YY, Roden RB, Hildesheim A, Wang Z, Reynolds MJ, Mast TC, Robinson R, Murphy BR, Karron RA, Dillner J, Schiller JT, Lowy DR.

J Natl Cancer Inst. 2001 Feb 21;93(4):284-92.

PMID:
11181775
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.

Han JE, Wui SR, Park SA, Lee NG, Kim KS, Cho YJ, Kim HJ, Kim HJ.

Vaccine. 2012 Jun 13;30(28):4127-34. doi: 10.1016/j.vaccine.2012.04.079. Epub 2012 May 1.

PMID:
22561312
[PubMed - indexed for MEDLINE]
8.

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB.

J Virol. 2005 Jun;79(11):6741-50.

PMID:
15890912
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88.

Yang R, Murillo FM, Delannoy MJ, Blosser RL, Yutzy WH 4th, Uematsu S, Takeda K, Akira S, Viscidi RP, Roden RB.

J Immunol. 2005 Jun 15;174(12):7912-9.

PMID:
15944297
[PubMed - indexed for MEDLINE]
Free Article
10.

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.

Pedersen C, Petaja T, Strauss G, Rumke HC, Poder A, Richardus JH, Spiessens B, Descamps D, Hardt K, Lehtinen M, Dubin G; HPV Vaccine Adolescent Study Investigators Network.

J Adolesc Health. 2007 Jun;40(6):564-71.

PMID:
17531764
[PubMed - indexed for MEDLINE]
11.

Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.

Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A.

J Infect Dis. 2003 Jul 15;188(2):327-38. Epub 2003 Jul 9.

PMID:
12854090
[PubMed - indexed for MEDLINE]
Free Article
12.

Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody.

Liu DW, Chang JL, Tsao YP, Huang CW, Kuo SW, Chen SL.

Int J Cancer. 2005 Jan 1;113(1):93-100.

PMID:
15386434
[PubMed - indexed for MEDLINE]
13.

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

Zhang T, Xu Y, Qiao L, Wang Y, Wu X, Fan D, Peng Q, Xu X.

Vaccine. 2010 Apr 26;28(19):3479-87. doi: 10.1016/j.vaccine.2010.02.057. Epub 2010 Mar 6.

PMID:
20211219
[PubMed - indexed for MEDLINE]
14.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G; GlaxoSmithKline HPV Vaccine Study Group.

Lancet. 2004 Nov 13-19;364(9447):1757-65.

PMID:
15541448
[PubMed - indexed for MEDLINE]
15.

Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.

Schellenbacher C, Roden R, Kirnbauer R.

J Virol. 2009 Oct;83(19):10085-95. doi: 10.1128/JVI.01088-09. Epub 2009 Jul 29.

PMID:
19640991
[PubMed - indexed for MEDLINE]
Free PMC Article
16.
17.

Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice.

Caulfield MJ, Shi L, Wang S, Wang B, Tobery TW, Mach H, Ahl PL, Cannon JL, Cook JC, Heinrichs JH, Sitrin RD.

Hum Vaccin. 2007 Jul-Aug;3(4):139-45. Epub 2007 Apr 5.

PMID:
17581283
[PubMed - indexed for MEDLINE]
Free Article
18.

Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant.

Oh YK, Sohn T, Park JS, Kang MJ, Choi HG, Kim JA, Kim WK, Ko JJ, Kim CK.

Virology. 2004 Oct 25;328(2):266-73.

PMID:
15464846
[PubMed - indexed for MEDLINE]
Free Article
19.

Effect of vaccine delivery system on the induction of HPV16L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques.

Tobery TW, Smith JF, Kuklin N, Skulsky D, Ackerson C, Huang L, Chen L, Cook JC, McClements WL, Jansen KU.

Vaccine. 2003 Mar 28;21(13-14):1539-47.

PMID:
12615451
[PubMed - indexed for MEDLINE]
20.

Papillomavirus-like particle vaccines.

Schiller JT, Lowy DR.

J Natl Cancer Inst Monogr. 2001;(28):50-4. Review.

PMID:
11158207
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk